ClinicalTrials.Veeva

Menu

Enhancing Inhibition With tDCS in Low Back Pain

A

Aalborg University

Status

Completed

Conditions

Low Back Pain

Treatments

Device: High-Definition Transcranial Direct Current Stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT03864822
VN-20170034-v5

Details and patient eligibility

About

This cross-over study intends to use consecutive days of active versus sham transcranial direct current stimulation (tDCS) to enhance descending inhibition and look at resulting clinical effects in people with low back pain.

Enrollment

12 patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Otherwise healthy men and women
  • Aged 18-60 years
  • Continuous pain (>3days pain/week) episode lasting at least 3 months, sufficient to limit daily activities
  • Pain in the region posteriorly between the inferior border of the 12th rib and the lower gluteal fold (low back pain) at the time of recruitment
  • Able to speak, read and understand English

Exclusion criteria

  • Pregnancy
  • Low back pain associated with menstruation
  • Currently seeking active treatment for low back pain
  • Red flags symptoms (i.e. fever, malaise, progressive neurologic deficit, significant trauma, prolonged corticosteroid use or osteoporosis, pain worst at night, urinary or faecal incontinence, or unintended weight loss)
  • Drug addiction defined as the use of cannabis, opioids or other drugs
  • Current or previous neurologic, musculoskeletal, mental, or other illnesses which may affect the trial
  • Current or previous chronic or recurrent pain condition other than low back pain
  • Current regular use of analgesic medication or other medication which may affect the trial
  • Lack of ability to cooperate

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

12 participants in 2 patient groups, including a placebo group

Active tDCS
Experimental group
Description:
30s ramp to 2mA with 20 minute session of active High-Definition Transcranial Direct Current Stimulation at 2mA
Treatment:
Device: High-Definition Transcranial Direct Current Stimulation
Sham tDCS
Placebo Comparator group
Description:
30s ramp to 2mA with High-Definition Transcranial Direct Current Stimulation, then device stops stimulating for 20 minutes
Treatment:
Device: High-Definition Transcranial Direct Current Stimulation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems